Back to the main directory
Press Release
- Fly Play hf.: Tillögur og dagskrá aðalfundar Fly Play hf. þriðjudaginn 7. mars 2023 by GlobeNewsWire
- uniQure announces the European Commission approval of the first gene therapy for adults with hemophilia B by GlobeNewsWire
- Tactile Systems Technology, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results; Introduces Full Year 2023 Outlook by GlobeNewsWire
- Walmart raises annual dividend to $2.28 per share, marking 50th consecutive year of dividend increases by BusinessWire
- Gestion mondiale d’actifs CI élargit sa gamme de stratégies d’options d’achat couvertes avec un nouveau FNB et quatre fonds communs de placement by BusinessWire
- EQS-News: HIKMICRO expose ses nouveaux produits aux salons extérieurs leaders BSS et IWA 2023 by EQS Group AG
- Arcadis IBI Group’s CurbIQ Solution Gains Momentum with Two New Curbside Management Software Implementations in North America and Europe by GlobeNewsWire
- EQS-News: Good start in 2023 after challenging fiscal year 2022 by EQS Group AG
- Rights and Issues Investment Trust PLC: NAV-Net Asset Value(s) by EQS Group AG
- Verrica Announces Pricing of $32.5 Million Underwritten Offering of Common Stock and Pre-Funded Warrants by GlobeNewsWire
- Almaden Signs Cooperation Agreement with Ejido Santa María Zotoltepec by GlobeNewsWire
- Harmony Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results and Business Updates by GlobeNewsWire
- Lincoln Electric Reports Fourth Quarter and Full Year 2022 Results by GlobeNewsWire
- Ebix Hosts its Largest Customer Conference Beginning Today by GlobeNewsWire
- Tearlach Resources Recognized as a Top 10 Ranked Company in the Mining Sector by the TSX Venture 50 for 2022 by GlobeNewsWire
- Sensei Biotherapeutics Presents Preclinical Data for SNS-101, a Conditionally Active VISTA-blocking Antibody, at the Keystone Symposia on Next Generation Antibody Therapeutics by GlobeNewsWire
- UPDATE ON FILING OF QUARTERLY REPORTS ON FORM 10-Q FOR THE QUARTERS ENDED JUNE 30, 2022 AND SEPTEMBER 30 2022 by GlobeNewsWire
- Theralase® Awarded TSX Venture 50™ Recognition as a Top Performing Company by GlobeNewsWire
- Brim: Birting ársreiknings 2022, fimmtudaginn 23. febrúar 2023 by GlobeNewsWire
- Lulus to Report Fourth Quarter and Full Year 2022 Results on March 14, 2023 by GlobeNewsWire
- Rhythm Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results on Wednesday, March 1, 2023 by GlobeNewsWire
- 89bio to Present Additional Pegozafermin Data in Severe Hypertriglyceridemia from Phase 2 ENTRIGUE Study at American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology by GlobeNewsWire
- Gaia Sets Fourth Quarter and Full Year 2022 Conference Call for Monday, March 6, 2023, at 4:30 p.m. ET by GlobeNewsWire
- Vor Bio to Participate in Upcoming Investor Conferences by GlobeNewsWire
- Nautilus Biotechnology to Participate in the 43rd Annual Cowen Health Care Conference by GlobeNewsWire